|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
118,810 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$3,602,319 |
|
|
Indirect Value
|
$6,313,200 |
|
|
Total
Shares |
327,029 |
|
|
Total
Value |
$9,915,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
Percentage
Gain/Loss : |
0.0%
|
-332.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-08-21 |
118,810 |
2024-08-21 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-01-04 |
4/A |
OE |
$5.28 |
$31,416 |
I/I |
5,950 |
184,075 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-01-04 |
4 |
AS |
$19.30 |
$118,084 |
D/D |
(5,950) |
2,777 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$24.51 |
$152,503 |
D/D |
(6,135) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
OE |
$5.28 |
$32,393 |
D/D |
6,135 |
6,135 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-08-23 |
4 |
AS |
$48.91 |
$300,454 |
I/I |
(6,143) |
158,630 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4/A |
AS |
$24.51 |
$155,194 |
D/D |
(6,242) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4/A |
OE |
$5.28 |
$32,958 |
D/D |
6,242 |
6,242 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-07-08 |
4 |
OE |
$5.28 |
$34,378 |
D/D |
6,511 |
7,988 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-07-08 |
4 |
AS |
$19.93 |
$132,187 |
D/D |
(6,511) |
4,081 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-03-01 |
4 |
AS |
$64.54 |
$470,741 |
I/I |
(7,092) |
165,141 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-02-05 |
4 |
OE |
$5.28 |
$41,480 |
D/D |
7,856 |
7,856 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$25.29 |
$238,864 |
I/I |
(9,445) |
132,670 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-07-08 |
4 |
AS |
$20.21 |
$222,825 |
I/I |
(10,989) |
79,934 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-06-10 |
4 |
AS |
$18.78 |
$241,943 |
I/I |
(12,883) |
90,923 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-09-04 |
4 |
AS |
$19.05 |
$333,375 |
I/I |
(17,500) |
200,890 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4/A |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2018-12-03 |
4 |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
148,390 |
0 |
- |
|
111 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|